Cite
HARVARD Citation
Wu, Q. et al. (2023). Cholinergic drugs reduce metabolic inflammation and diabetic myocardial injury by regulating the gut bacterial component lipopolysaccharide‐induced ERK/Egr‐1 pathway. FASEB journal. 37 (5), p. n/a. [Online].